Pharmacology: Difference between revisions
No edit summary |
No edit summary |
||
| Line 11: | Line 11: | ||
[http://www.substanceabusepolicy.com/content/1/1/15 Misuse of "study drugs:" prevalence, consequences, and implications for policy]<br>Steve Sussman, Mary A Pentz, Donna Spruijt-Metz and Toby Miller | [http://www.substanceabusepolicy.com/content/1/1/15 Misuse of "study drugs:" prevalence, consequences, and implications for policy]<br>Steve Sussman, Mary A Pentz, Donna Spruijt-Metz and Toby Miller | ||
<br> | == <br>Neuro-pharmacology == | ||
[http://onlinelibrary.wiley.com/doi/10.1111/j.1742-7843.2007.00159.x/full The Dark Side of Ecstasy: Neuropsychiatric Symptoms After Exposure to 3,4-Methylenedioxymetamphetamine]<br>Sunniva Nyberg Karlsen, Olav Spigset, LARS Slørdal<br> | [http://onlinelibrary.wiley.com/doi/10.1111/j.1742-7843.2007.00159.x/full The Dark Side of Ecstasy: Neuropsychiatric Symptoms After Exposure to 3,4-Methylenedioxymetamphetamine]<br>Sunniva Nyberg Karlsen, Olav Spigset, LARS Slørdal<br> | ||
| Line 23: | Line 19: | ||
[http://onlinelibrary.wiley.com/doi/10.1111/j.1360-0443.2010.03252.x/full Residual neurocognitive features of long-term ecstasy users with minimal exposure to other drugs]<br>John H. Halpern, Andrea R. Sherwood, James I. Hudson, Staci Gruber, David Kozin, Harrison G. Pope Jr | [http://onlinelibrary.wiley.com/doi/10.1111/j.1360-0443.2010.03252.x/full Residual neurocognitive features of long-term ecstasy users with minimal exposure to other drugs]<br>John H. Halpern, Andrea R. Sherwood, James I. Hudson, Staci Gruber, David Kozin, Harrison G. Pope Jr | ||
<br>[http://www.substanceabusepolicy.com/content/3/1/22 Coming to terms with the nonmedical use of prescription medications]<br>Carol J Boyd and Sean E McCabe | [http://www.peh-med.com/content/pdf/1747-5341-3-14.pdf Effectiveness of antidepressants: an evidence myth constructed<br>from a thousand randomized trials]?<br>John PA Ioannidis | ||
[http://www.peh-med.com/content/pdf/1747-5341-6-8.pdf Should We Treat Depression with drugs or<br>psychological interventions? A Reply to Ioannidis]<br>John M Davis, William J Giakas, Jie Qu, Pavan Prasad and Stefan Leucht<br><br>[http://www.substanceabusepolicy.com/content/3/1/22 Coming to terms with the nonmedical use of prescription medications]<br>Carol J Boyd and Sean E McCabe | |||
<br> | <br> | ||
Revision as of 11:15, 11 July 2011
Introduction (coming soon)
Drugs 'R Us
Dave Boothroyd
Socio-pharmacology
Epidemiology Meets Cultural Studies: Studying and Understanding Youth Cultures, Clubs and Drugs
Geoffrey Hunt, Molly Moloney, and Kristin Evans
Misuse of "study drugs:" prevalence, consequences, and implications for policy
Steve Sussman, Mary A Pentz, Donna Spruijt-Metz and Toby Miller
Neuro-pharmacology
The Dark Side of Ecstasy: Neuropsychiatric Symptoms After Exposure to 3,4-Methylenedioxymetamphetamine
Sunniva Nyberg Karlsen, Olav Spigset, LARS Slørdal
Residual neurocognitive features of long-term ecstasy users with minimal exposure to other drugs
John H. Halpern, Andrea R. Sherwood, James I. Hudson, Staci Gruber, David Kozin, Harrison G. Pope Jr
Effectiveness of antidepressants: an evidence myth constructed
from a thousand randomized trials?
John PA Ioannidis
Should We Treat Depression with drugs or
psychological interventions? A Reply to Ioannidis
John M Davis, William J Giakas, Jie Qu, Pavan Prasad and Stefan Leucht
Coming to terms with the nonmedical use of prescription medications
Carol J Boyd and Sean E McCabe
Ethno-pharmacology
Naming a Phantom - the Quest to Find the Identity of the Ulluchu, an Unidentified Cerimonial Plant of the Moche Culture in Northern Peru
Rainer W Bussmann and Douglas Sharon
Absinthism: A Fictitious 19th. Centrury Syndrome with Present Impact
Stephan A Padosch, Dirk W Lachenmeier and Lars U Kröner
Juridico-pharmacology
Our Right to Drugs
An interview with Thomas Szasz
Global Commission on Drugs Report (2011)
Drug Policy – Lessons Learnt, and Options for the Future
Mike Trace
The UK’s Treatment War on Drugs: A Lesson in Unintended Consequences and Perverse Outcomes
Kathy Gyngell
Cultural psycho-pharmacology
Timothy Leary, Cooper Union Addess, 1964